about
Drug discovery prospect from untapped species: indications from approved natural product drugsWhat does it take to synergistically combine sub-potent natural products into drug-level potent combinations?The Assessment of the Readiness of Molecular Biomarker-Based Mobile Health Technologies for Healthcare ApplicationsIn silico prediction of adverse drug reactions and toxicities based on structural, biological and clinical data.Effect of training data size and noise level on support vector machines virtual screening of genotoxic compounds from large compound libraries.RUNX3 mediates suppression of tumor growth and metastasis of human CCRCC by regulating cyclin related proteins and TIMP-1.Prediction of RNA-binding proteins from primary sequence by a support vector machine approach.A real-time fluorescence polarization activity assay to screen for inhibitors of bacterial ribonuclease POverexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.Decitabine of reduced dosage in Chinese patients with myelodysplastic syndrome: a retrospective analysisCFam: a chemical families database based on iterative selection of functional seeds and seed-directed compound clustering.The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal InjurySVM-Prot 2016: A Web-Server for Machine Learning Prediction of Protein Functional Families from Sequence Irrespective of Similarity.Simultaneous Quantification of Anticardiolipin IgG and IgM by Time Resolved Fluoroimmunoassay.Discovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approach.HEROD: a human ethnic and regional specific omics database.Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.Advances in machine learning prediction of toxicological properties and adverse drug reactions of pharmaceutical agents.Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1).Molecular basis of therapeutic approaches to gastric cancer.Prediction of functional class of proteins and peptides irrespective of sequence homology by support vector machines.Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.Therapeutic target database update 2014: a resource for targeted therapeutics.Clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites.The Therapeutic Target Database: an internet resource for the primary targets of approved, clinical trial and experimental drugs.Polymorphisms in the vitamin D receptor gene and risk of primary biliary cirrhosis: a meta-analysis.Neuroprotective gases--fantasy or reality for clinical use?Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs.Predicting the Enzymatic Hydrolysis Half-lives of New Chemicals Using Support Vector Regression Models Based on Stepwise Feature Elimination.Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP-1.Human mitochondrial Mrs2 protein promotes multidrug resistance in gastric cancer cells by regulating p27, cyclin D1 expression and cytochrome C release.Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer.Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS.Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer.Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO.Detection of Hepatitis B Virus Large Surface Protein Using a Time-Resolved Immunofluorometric Assay.p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.BSFINDER: finding binding sites of HCV proteins using a support vector machine.Nicotine-induced neuroprotection against ischemic injury involves activation of endocannabinoid system in rats.
P50
Q28481257-383DE8C5-9FFE-4D3C-94DC-106FB3C99D68Q28485360-3AE28678-268D-4756-A64F-961AB4382652Q30396334-D31BDD6A-65A3-4016-A17F-DD83A10D9F83Q30561373-05B33351-47B7-419D-8F0E-375894FEA6B4Q33894051-4819E082-C41D-4156-808A-79D0E40C5528Q34211698-E96502B4-EB41-4228-9728-EF86B0368CBCQ34366898-1326937D-ADA7-4A97-834F-34F7BC1DC575Q34489660-DDA26257-7BF7-426F-BF19-A99F806CF8E0Q34614359-814B32D7-37D3-40DE-B594-AF841BD71B11Q34629446-2E617553-18B8-49E9-B880-022C30E12AA4Q35153059-F4D96D8D-363A-428A-BFC4-F6B4FA853F41Q35254424-43659D1B-D305-4DE8-8F5B-29109DAD24CEQ35619730-AEDD8DEC-6832-4085-8E48-294089ACC4C2Q36104137-2E24956E-394C-4345-AEB4-3325C4D61F34Q36142382-B1073D9F-E723-4B93-8FA7-56E529D405DEQ36229209-E935F8E2-79EA-4A66-9AA1-AFFC0E92F12AQ36382897-E93C16F8-A450-480A-AE34-69927F445D99Q36434850-569FA2AA-6CC6-4777-ACC3-556C8ADBA5A0Q37239548-9341C4A6-9548-4784-B66B-F465968CDE5BQ37294503-7D6746FE-BFC2-416C-B8AC-E73CE5531F13Q37386372-3FB04C89-6DDE-4B96-AC8A-324E88D87A68Q37462980-29EC601F-3F7E-4984-A41C-3FCAAE5C6775Q37481572-6DA4A909-9262-4245-A1C4-9A38218B4166Q37661746-6D478263-3291-43A6-9859-7D07B18D814BQ37737158-2F5217B1-B7F6-430A-91F4-D369A663848EQ37880903-D12D0B8A-2D63-47AA-AD64-98DA79485C18Q38162283-858E8347-0AC1-42EB-9FB8-CAF942635FE3Q38179800-0836B267-E558-40EC-B3D4-82B98C2216B6Q38599876-EDFFBD66-354F-4E21-9DA5-F366E845C89EQ38719496-4D76BD77-04BA-4A9A-8F2B-E8C4E5F2FD53Q39624414-C62671A8-0140-45C2-82EE-D3B5CC3885F8Q39880017-5CFDE70F-B11A-43B2-8087-E667A9B67D50Q40028825-D990B033-858F-462E-921B-DA378676C0C7Q40149480-5D194E9C-35DF-442C-A263-1D0F23C41A98Q40341951-28CB0A6B-CB3E-4F08-9809-68175AD38566Q40606498-C2E9BA77-5260-4397-B7EE-6225B9ACF65CQ41718291-EBB266EB-5865-47A3-B736-BEC1CAFF8329Q42144686-CD817FD2-B960-46A4-A16F-7B734FBEA784Q42986795-F7B0CB59-8CBB-4BC2-8109-546A63857938Q44793980-7655E63A-8AFE-4801-907E-DE55329818B4
P50
name
Yu Zong Chen
@en
Yu Zong Chen
@nl
type
label
Yu Zong Chen
@en
Yu Zong Chen
@nl
prefLabel
Yu Zong Chen
@en
Yu Zong Chen
@nl